Your browser doesn't support javascript.
loading
Efficacy and Safety of First-line Single-Agent Carboplatin vs Carboplatin Plus Paclitaxel for Vulnerable Older Adult Women With Ovarian Cancer: A GINECO/GCIG Randomized Clinical Trial.
Falandry, Claire; Rousseau, Frédérique; Mouret-Reynier, Marie-Ange; Tinquaut, Fabien; Lorusso, Domenica; Herrstedt, Jørn; Savoye, Aude-Marie; Stefani, Laetitia; Bourbouloux, Emmanuelle; Sverdlin, Robert; D'Hondt, Veronique; Lortholary, Alain; Brachet, Pierre-Emmanuel; Zannetti, Alain; Malaurie, Emmanuelle; Venat-Bouvet, Laurence; Trédan, Olivier; Mourey, Loïc; Pujade-Lauraine, Eric; Freyer, Gilles.
Afiliação
  • Falandry C; Groupe d'Investigateurs Nationaux pour l'Étude des Cancers de l'Ovaire et du sein (GINECO), Laboratoire CarMEN, INSERM U1060/INRA U1397, Université Lyon 1, INSA de Lyon, and Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France.
  • Rousseau F; GINECO and Institut Paoli Calmettes, Marseille, France.
  • Mouret-Reynier MA; GINECO and Centre Jean Perrin, Clermont-Ferrand, France.
  • Tinquaut F; GINECO and Institut de Cancérologie de la Loire, St Priest en Jarez, France.
  • Lorusso D; Multicentre Italian Trials in Ovarian cancer (MITO) and Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, and Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy.
  • Herrstedt J; Nordic Society of Gynecologic Oncology (NSGO), Odense University Hospital, Odense, and Zealand University Hospital, Roskilde, Denmark.
  • Savoye AM; GINECO and Institut Jean Godinot, Reims, France.
  • Stefani L; GINECO and Centre Hospitalier Annecy Genevois, Pringy, France.
  • Bourbouloux E; GINECO and Institut de Cancérologie de l'Ouest René Gauducheau, Saint Herblain, France.
  • Sverdlin R; GINECO and Groupe Hospitalier Paris Saint Joseph, Paris, France.
  • D'Hondt V; GINECO and Institut du Cancer de Montpellier, Montpellier, France.
  • Lortholary A; GINECO and Hôpital Privé du Confluent, Nantes, France.
  • Brachet PE; GINECO and Centre François Baclesse, Caen, France.
  • Zannetti A; GINECO and Centre Hospitalier de Cholet, Cholet, France.
  • Malaurie E; GINECO and Centre Hospitalier Intercommunal de Créteil, Créteil, France.
  • Venat-Bouvet L; GINECO and Centre Hospitalier Universitaire Dupuytren, Limoges, France.
  • Trédan O; GINECO and Centre Léon Bérard, Lyon, France.
  • Mourey L; GINECO and Institut Claudius Regaud, Toulouse, France.
  • Pujade-Lauraine E; GINECO, Paris, France.
  • Freyer G; GINECO and Centre Hospitalier Lyon-Sud, Lyon, France.
JAMA Oncol ; 7(6): 853-861, 2021 Jun 01.
Article em En | MEDLINE | ID: mdl-33885718
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Aged / Aged80 / Female / Humans Idioma: En Revista: JAMA Oncol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Aged / Aged80 / Female / Humans Idioma: En Revista: JAMA Oncol Ano de publicação: 2021 Tipo de documento: Article